Toxopain-1 Is Critical for Infection in a Novel Chicken Embryo Model of Congenital Toxoplasmosis

Infection and Immunity

Volumn 72, Issue 5, 2004, Pages 2915-2921

  Que, Xuchu ^a   Wunderlich, Annette ^a   Joiner, Keith A ^b,d   Reed, Sharon L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UCSD MEDICAL CENTER   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CATHEPSIN B; CYSTEINE PROTEINASE; TOXOPAIN 1; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHICKEN; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DISEASE MODEL; DRUG SCREENING; DRUG TARGETING; EMBRYO; ENZYME ACTIVITY; HISTOPATHOLOGY; IN VIVO STUDY; INHIBITION KINETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES COMPARISON; TOXOPLASMA;

ANIMALS; BASE SEQUENCE; CHICK EMBRYO; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; DNA, PROTOZOAN; GENE EXPRESSION; GENES, PROTOZOAN; HUMANS; RNA, ANTISENSE; RNA, MESSENGER; RNA, PROTOZOAN; SPECIES SPECIFICITY; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TOXOPLASMOSIS, CEREBRAL; TOXOPLASMOSIS, CONGENITAL;

EID: 2142647845     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.5.2915-2921.2004     Document Type: Article

References (19)

1. Burg, J. L., D. Perelman, L. H. Kasper, P. L. Ware, and J. C. Boolhroyd. 1988. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J. Immunol. 141:3584-3591.
2. Dan, M., A. L. Wang, and C. C. Wang. 2000. Inhibition of pyruvate-ferredoxin oxidoreductase gene expression in Giardia lamblia by a virus-mediated hammerhead ribozyme. Mol. Microbiol. 36:447-456.
3. Donald, R. G., and D. S. Roos. 1998. Gene knock-outs and allelic replacements in Toxoplasma gondii: HXGPRT as a selectable marker for hit-and-run mutagenesis. Mol. Biochem. Parasitol. 91:295-305.
4. Eggleson, K. K., K. L. Duffin, and D. E. Goldberg. 1999. Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum. J. Biol. Chem. 274:32411-32419.
5. Engel, J. C., P. S. Doyle, I. Hsieh, and J. H. McKerrow. 1998. Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J. Exp. Med. 188:725-734.
6. Greenhaum, D. C., A. Baruch, M. Grainger, Z. Bozdech, K. F. Medzihradskzy, J. Engel, J. DeRisi, A. A. Holder, and M. Bogyo. 2002. A role for the protease falcipain-1 in host cell invasion by the human malaria parasite. Science 298:2002-2006.
7. Harth, G., N. Andrews, A. A. Mills, J. C. Engel, R. Smith, and J. H. McKerrow. 1993. Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi. Mol. Biochem. Parasitol. 58:17-24.
8. Kim, J., W. Yu, K. Kovalski, and L. Ossowski. 1998. Requirement for specific proteases in cancer cell intravassation as revealed by a novel semiquantitative PCR-based assay. Cell 94:353-362.
9. Luft, B. J., and J. S. Remington. 1992. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:211-222.
10. McAuley, J., K. M. Boyer, D. Patel, M. Mets, C. Swisher, N. Roizen, C. Wolters, L. Stein, M. Stein, W. Schey, J. Remington, P. Meier, D. Johnson, P. Heydeman, E. Holfels, S. Withers, D. Mack, C. Brown, D. Patton, and R. McLeod. 1994. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin. Infect. Dis. 18:38-72.
11. McGrath, M. E., A. E. Eakin, J. C. Engel, J. H. McKerrow, C. S. Craik, and R. J. Fletterick. 1995. The crystal structure of cruzain: a therapeutic target for Chagas' disease. J. Mol. Biol. 247:251-259.
12. McLeod, R., K. Boyer, N. Roizen, L. Stein, C. Swisher, E. Holfels, J. Hopkins, D. Mack, T. Karrison, D. Patel, L. Pfiffner, J. Remington, S. Withers, S. Meyers, V. Aitchison, M. Mets, P. Rabiah, and P. Meier. 2000. The child with congenital toxoplasmosis. Curr. Clin. Top. Infect. Dis. 20:189-208.
13. Nakaar, V., E. O. Ngo, and K. A. Joiner. 2000. Selection based on the expression of antisense hypoxanthine-xanthine-guanine-phosphoribosyl-transferase RNA in Toxoplasma gondii. Mol. Biochem. Parasitol. 110:43-51.
14. Nakaar, V., H. M. Ngo, E. P. Aaronson, I. Coppens, T. T. Stedman, and K. A. Joiner. 2003. Pleiotrpic effect due to targeted depletion of secretory rhopty protein ROP2 in Toxoplasma gondii. J. Cell Sci. 116:2311-2320.
15. Nakaar, V., B. U. Samuel, E. O. Ngo, and K. A. Joiner. 1999. Targeted reduction of nucleoside triphosphate hydrolase by antisense RNA inhibits Toxoplasma gondii proliferation. J. Biol. Chem. 274:5083-5087.
16. Que, X., H. Ngo, J. Lawton, M. Gray, Q. Liu, J. Engel, L. Briuen, P. Ghosh, K. A. Joiner, and S. L. Reed. 2002. The cathepsin B of Toxoplasma gondii, toxopain-1, is critical for parasite invasion and rhoptry protein processing. J. Biol. Chem. 277:25791-25797.
17. Sajid, M., and J. H. McKerrow. 2002. Cysteine proteases of parasitic organisms. Mol. Biochem. Parasitol. 120:1-21.
18. Selzer, P. M., X. Chen, V. J. Chan, M. Cheng, G. L. Kenyon, I. D. Kuntz, J. A. Sakanari, F. E. Cohen, and J. H. McKerrow. 1997. Leishmania major: molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors. Exp. Parasitol. 87:212-221.
19. Sijwali, P. S., B. R. Shenai, J. Gut, A. Singh, and P. J. Rosenthal. 2001. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Biochem. J. 360:481-489.